Takeda Oncology’s Post

How do clinical data experts contribute to Oncology research? This #worldcancerday hear from our team Tikson Poulose Prabhudas Anabhathula Shakila J and Satish Kumar Jayasekar as they share their journey of contributing to cancer research. Every trial we support is an opportunity to bring a new therapy to market, holding the potential to change millions of patient lives, while closing the care gap. #inthistogether #closethecaregap #worldcancerday #4feb #dataexperts #changinglives #oncologyresearch #newtreatments

#Paper | Recommendations for the Equitable and Widespread Implementation of #LiquidBiopsy for Cancer Care American Society of Clinical Oncology (ASCO) Access the entire article here 👇

The future of oncology with 'Radiotheranostics: Making Precision Medicine Possible.' Learn how targeted radiopharmaceuticals revolutionize cancer treatment. A must-read for healthcare pioneers! #pubrica #Radiotheranostics #OncologyInnovation  Learn More: https://lnkd.in/gUzXr74y

Explore the intricacies of cancer risk with Dr. Ashwin K R, a distinguished expert in Surgical Oncology at Aster Whitefield. Gain insights into the factors influencing cancer risk, distinguishing between modifiable and non-modifiable aspects. Delve into the full conversation for a holistic grasp of this critical topic. #CancerRisk #PatientCare #OncologyExpertise #CancerTreatment #HealthcareAwareness #AsterWhitefield #AsterBangalore #AsterHospitals

Check out the latest white paper from Friends of Cancer Research including input from Parexel's Dr. Amy McKee, Chief Medical Officer and Head of Oncology Center of Excellence. The paper explores the inclusion of pragmatic elements in trial designs to enhance randomized oncology clinical trials while highlighting the potential benefits of reducing trial complexity such as improved patient enrollment and reduced attrition. The importance of broadening eligibility criteria in clinical trials to make them more representative of diverse populations is also addressed. Take a sneak peek below and click here for the full paper: https://lnkd.in/gEU5juYk #clinicaltrials #cancertreatment

Understanding and Preventing Cervical Cancer Nouzha WiNMI leader,Group Expert of WiN Global EANM _WE Vp #WiN Global,#WiNMI,#WiN for peace,#WiN YG,#WiN Africa,#WiN IAEA,#WiN France,#WiN Europe,#AMMN ,#SNMMI,#PSNM,#AI,#Nuclear Medicine,#Oncology,#Molecular Imaging,#Myocardial imaging,#ASCO,#EANM,#EANM_WE,#EANM_WE, #WARMTH, #alpha Therapy, #beta Nuclear Medicine therapyVp,#Oncidium,#ESMIT,#SFMN,#UCLA,#EJNMMI,#Americanoncologyinstitute,#Urology,#Prostate,#TNE,#WiA,#Gliomas,#Lymphomas,#Burkitt,#PRRT,#211At,#Neurology,#Alzheimer,#Thyroid cancer,#Cardiac Amyloidosis

Nonadherence is not as simple as forgetfulness. As behavioral scientists we dive deep to understand intentional nonadherence and use evidence-based and highly personalized techniques to nudge behavior change.

The intricacies of esophageal cancer management, particularly squamous cell carcinoma, demand our attention as healthcare marketers. Engaging with the latest research, such as the implications of PD-L1 testing and evolving treatment paradigms, is crucial for tailoring our strategies. Understanding these nuances not only informs our messaging but also enhances patient outcomes. Dive into the expert discussions that'll shape the future of healthcare marketing in oncology. #HealthcareMarketing #OncologyInsights

We highlight the overuse of terms such as 'tolerable', 'manageable' and 'acceptable' in reports of clinical trials - Edward Cliff oncodaily.com/20876.html #oncodaily #oncology #cancer #JAMA #research

Sharing valuable insights on the power of Immunotherapy in cancer treatment! Dr. Sunny Garg, HOD & Senior Consultant of Medical Oncology at Sanar International Hospitals, sheds light on the latest advancements and breakthroughs in the field. #Immunotherapy #CancerTreatment #MedicalOncology #ExpertInsights